Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Monoclonal antibodies to human hemoglobin S and cell lines for the production thereof

Patent ·
OSTI ID:5577044

The present invention provides monoclonal antibodies specific to and distinguishing between hemoglobin S and hemoglobin A and methods for their production and use. These antibodies are capable of distinguishing between two hemoglobin types which differ from each other by only a single amino acid residue. The antibodies produced according to the present method are useful as immunofluorescent markers to enumerate circulating red blood cells which have the property of altered expression of the hemoglobin gene due to somatic mutation in stem cells. Such a measurement is contemplated as an assay for in vivo cellular somatic mutations in humans. Since the monoclonal antibodies produced in accordance with the instant invention exhibit a high degree of specificity to and greater affinity for hemoglobin S, they are suitable for labeling human red blood cells for flow cytometric detection of hemoglobin genotype. 4 figs.

Research Organization:
Lawrence Livermore National Lab., CA (USA)
DOE Contract Number:
W-7405-ENG-48
Assignee:
Dept. of Energy
Patent Number(s):
None
Application Number:
ON: DE86013864
OSTI ID:
5577044
Country of Publication:
United States
Language:
English